# Indivior Pharmaceuticals, Inc.: Form 8-K, filed Oct 1, 2025

- Company: [Indivior Pharmaceuticals, Inc.](/companies/indv.md) (CIK 1625297)
- Form: 8-K
- Filed: 2025-10-01
- Accepted by EDGAR: Oct 1, 2025, 08:01 ET
- Period: 2025-10-01
- Accession: 0001628280-25-043293
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1625297/000162828025043293/indv-20251001.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1625297/000162828025043293/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1625297/000162828025043293/indv-20251001.htm

Filed Oct 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-043293. Last ingested by Listed: Oct 29, 2026, 08:21 ET. No prices; not investment advice.